Genesystem Co (XKRX:363250) Pre-Tax Income : ₩-8,110.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Genesystem Co's pretax income for the three months ended in Mar. 2024 was ₩-2,379.9 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-8,110.0 Mil. Genesystem Co's pretax margin was -1,760.12%.

During the past 5 years, Genesystem Co's highest Pretax Margin was 23.91%. The lowest was -1449.63%. And the median was -193.26%.

Genesystem Co Pre-Tax Income Historical Data

The historical data trend for Genesystem Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Pre-Tax Income Chart

Genesystem Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-4,041.00

-3,591.85

3,164.86

-7,059.75

-7,912.60

Genesystem Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial											-2,182.49	-1,917.84	-2,283.82	-1,528.45	-2,379.86

Competitive Comparison of Genesystem Co's Pre-Tax Income

For the Diagnostics & Research subindustry, Genesystem Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genesystem Co's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Genesystem Co's Pre-Tax Income falls into.

Genesystem Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Genesystem Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-9482.494	+	0	+	-133.606	+	363.746	+	1339.754
	=	-7,912.6

Genesystem Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-189.745	+	0	+	0	+	0	+	-2190.112
	=	-2,379.9

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,110.0 Mil.

Genesystem Co (XKRX:363250) Pre-Tax Income Explanation

Genesystem Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2379.857	/	135.21
	=	-1,760.12%

During the past 5 years, Genesystem Co's highest Pretax Margin was 23.91%. The lowest was -1449.63%. And the median was -193.26%.

Genesystem Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Genesystem Co (XKRX:363250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028

Website

http://www.genesystem.co.kr

Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines